Lonza News ٤ فبراير ٢٠٢٦ Barclays Reaffirms Their Buy Rating on Lonza Group Ltd (LONN) - The Globe and Mail
Lonza News ٤ فبراير ٢٠٢٦ Barclays Reaffirms Their Buy Rating on Lonza Group Ltd (LONN) - The Globe and Mail
Lonza News ٣٠ يناير ٢٠٢٦ CDMOs dominate the headlines – and Lonza delivers a clear message of strength - European Biotechnology Magazine
Lonza News ٢٩ يناير ٢٠٢٦ Lonza Group Continues To Leverage Biopharma’s Optimization Push (OTCMKTS:LZAGY) - Seeking Alpha
Lonza News ٢٩ يناير ٢٠٢٦ Narrow-Moat Lonza's Long-Term Outlook Driven by Strong Outsourced Drug Manufacturing Demand - Morningstar
Lonza News ٢٩ يناير ٢٠٢٦ Switzerland’s Lonza edges closer to sale of its capsule and health ingredients business - 93.3 The Drive
Lonza News ٢٨ يناير ٢٠٢٦ Lonza still intends to sell its capsules and health ingredients business - Endpoints News
Lonza News ٢٨ يناير ٢٠٢٦ Earnings call transcript: Lonza reports strong 2025 results, stock dips - Investing.com
Lonza News ٢٨ يناير ٢٠٢٦ Switzerland's Lonza edges closer to sale of its capsule and health ingredients business - Reuters
Lonza News ٢٨ يناير ٢٠٢٦ Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - Reuters
Lonza News ٢٨ يناير ٢٠٢٦ Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - wkzo.com